Oman vs Post-demographic dividend: Prevalence of anemia among non-pregnant women
Oman
34.4%
in 2023
Post-demographic dividend
15.8%
in 2023
Oman rank
46th
Post-demographic dividend rank
45th
Prevalence of anemia among non-pregnant women over time
- Oman
- Post-demographic dividend
How they compare
Oman currently reports 34.4% against 15.8% in Post-demographic dividend, a difference of 18.6%.
That makes Oman's figure about 2.2 times Post-demographic dividend's.
Across all 24 years both countries report, Oman has been ahead every year.
Oman ranks 46th and Post-demographic dividend ranks 45th of 192 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Post-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.8% | 11.5% | 25.4% | Oman |
| 2010s | 33.7% | 12.6% | 21.1% | Oman |
| 2020s | 34.0% | 14.9% | 19.1% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among non-pregnant women, Oman or Post-demographic dividend?
- Oman, at 34.4% against 15.8% in Post-demographic dividend as of 2023.
- What is the difference in prevalence of anemia among non-pregnant women between Oman and Post-demographic dividend?
- 18.6%, with Oman ahead.
- How many years of comparable data are there for Oman and Post-demographic dividend?
- 24 years are reported by both, from 2000 to 2023.
- How do Oman and Post-demographic dividend rank globally for prevalence of anemia among non-pregnant women?
- Oman ranks 46th and Post-demographic dividend ranks 45th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among non-pregnant women (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia, non-pregnant women, is the percentage of non-pregnant women whose hemoglobin level is less than 120 grams per liter at sea level.